Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008

Nature Reviews Drug Discovery

Volumn 8, Issue 6, 2009, Pages 455-463

  Michino, Mayako ^a   Abola, Enrique ^a   Brooks III, Charles L ^b   Scott Dixon, J ^c   Moult, John ^d   Stevens, Raymond C ^a   Olson, Arthur ^a   Jurkowski, Wiktor ^e   Elofsson, Arne ^e   Filipek, Slawomir ^f   Pogozheva, Irina ^b   Lomize, Andrei ^b   Maigret, Bernard ^g   Horst, Jeremy ^h   Roy, Ambrish ⁱ   Bernard, Brady ^h   Iyer, Shyamala ^h   Zhang, Yang ⁱ   Samudrala, Ram ^h   Sezerman, Osman Ugur ^j   Nikiforovich, Gregory V ^h   Taylor, Christina M ^h   Costanzi, Stefano ^k   Vorobjev, Y ^m   Bakulina, N ^m   Solovyev, V ^l,m   Kanou, Kazuhiko ⁿ   Takaya, Daisuke ^n,o   Terashi, Genki ⁿ   Takeda Shitaka, Mayuko ^n,o   Umeyama, Hideaki ^n,o   Goddard III, William A ^p   Li, Youyong ^p   Kim, Soo Kyung ^p   Trzaskowski, Bartosz ^p   Abrol, Ravinder ^p   Griffith, Adam ^p   Katritch, Vsevolod ^q   Rueda, Manuel ^q   Abagyan, Ruben ^a,q   Davis, Ian ^h   Barth, Patrick ^h   Baker, David ^h   Feig, Michael ^r   Brylinski, Michal ^s   Zhou, Hongyi ^s   Lee, Seung Yup ^s   Skolnick, Jeffrey ^s   Ostopovici Halip, Liliana ^t   Bologa, Cristian ^t   Lam, Polo ^a   Dawson, Eric S ^u   Kaufmann, Kristian ^u   Woetzel, Nils ^u   Meiler, Jens ^u   Ding, Feng ^v   Serohijos, Adrian ^v   Yin, Shuangye ^v   Dokholyan, Nikolay V ^v   Rodriguez, David ^w   Gutiérrez de Teràn, Hugo ^w   Xhaard, Henri ^x   more..

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Daylight Chemical Information Systems Inc   (United States)

^d UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^e STOCKHOLM UNIVERSITY   (Sweden)

^f International Institute of Molecular and Cell Biology   (United States)

^g LORIA   (France)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF KANSAS   (United States)

^j SABANCI UNIVERSITY   (Turkey)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^l UNIVERSITY OF LONDON   (United Kingdom)

^m SOFTBERRY INC   (United States)

ⁿ KITASATO UNIVERSITY   (Japan)

^o RIKEN   (Japan)

^p CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^q MOLSOFT LLC   (United States)

^r Michigan State University   (United States)

^s GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^t UNIVERSITY OF NEW MEXICO   (United States)

^u VANDERBILT UNIVERSITY   (United States)

^v UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^w UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^x UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2 RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; HUMAN; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR MODEL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 67349088738     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2877     Document Type: Article

References (37)

1. Jorgensen, W. L. The many roles of computation in drug discovery. Science 303, 1813-1818 (2004).
2. Richon, A. B. Current status and future direction of the molecular modeling industry. Drug Discov. Today 13, 665-669 (2008).
3. Kitchen, D. B., Decornez, H., Furr, J. R. & Bajorath, J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Rev. Drug Discov. 3, 935-949 (2004).
4. Drews, J. Drug discovery: A historical perspective. Science 287 1960-1964 (2000).
5. Klabunde, T. & Hessler, G. Drug design strategies for targeting G-protein-coupled receptors. Chembiochem. 3, 928-944 (2002).
6. Becker, O. M. et al. G protein-coupled receptors: in silico drug discovery in 3D. Proc. Natl Acad. Sci. USA 101, 11304-11309 (2004).
7. Ballesteros, J. & Palczewski, K. G protein-coupled receptor drug discovery: Implications from the crystal structure of rhodopsin. Curr. Opin. Drug Discov. Devel. 4, 561-574 (2001).
8. Bu, L., Michino, M., Wolf, R. M. & Brooks, C. L. III. Improved model building and assessment of the Calcium-sensing receptor transmembrane domain. Proteins 71, 215-226 (2008).
9. Henin, J. et al. Probing a model of a GPCR/ligand complex in an explicit membrane environment: The human cholecystokinin-1 receptor. Biophys. J. 90, 1232-1240 (2006).
10. Fowler, C. B., Pogozheva, I. D., LeVine, H., 3rd & Mosberg, H. I. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites. Biochemistry 43, 8700-8710 (2004).
11. Evers, A. & Klabunde, T. Structure-based drug discovery using GPCR homology modeling: Successful virtual screening for antagonists of the alpha1A adrenergic receptor. J. Med. Chem. 48, 1088-1097 (2005).
12. Manivet, P. et al. The serotonin binding site of human and murine 5-HT2B receptors: Molecular modeling and site-directed mutagenesis. J. Biol. Chem. 277, 17170-17178 (2002).
13. Archer, E., Maigret, B., Escrieut, C., Pradayrol, L. & Fourmy, D. Rhodopsin crystal: New template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol. Sci. 24, 36-40 (2003).
14. Gershengorn, M. C. & Osman, R. Minireview: Insights into G protein-coupled receptor function using molecular models. Endocrinology 142, 2-10 (2001).
15. Ballesteros, J. A., Shi, L. & Javitch, J. A. Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60, 1-19 (2001).
16. Kobilka, B. K. & Deupi, X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 28, 397-406 (2007).
17. Bhattacharya, S., Hall, S. E., Li, H. & Vaidehi, N. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: Insight into G-protein-coupled receptor activation. Biophys. J. 94, 2027-2042 (2008).
18. Kenakin, T. Efficacy at G-protein-coupled receptors. Nature Rev. Drug Discov. 1, 103-110 (2002).
19. Jaakola, V. P. et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211-1217 (2008).
20. Jacobson, K. A. & Gao, Z. G. Adenosine receptors as therapeutic targets. Nature Rev. Drug Discov. 5, 247-264 (2006).
21. Moult, J. et al. Critical assessment of methods of protein structure prediction-Round VII. Proteins 69 (Suppl. 8), 3-9 (2007).
22. Lensink, M. F., Mendez, R. & Wodak, S. J. Docking and scoring protein complexes: CAPRI 3rd Edition. Proteins 69, 704-718 (2007).
23. Kopp, J., Bordoli, L., Battey, J. N., Kiefer, F. & Schwede, T. Assessment of CASP7 predictions for template-based modeling targets. Proteins 69 (Suppl. 8), 38-56 (2007).
24. Kobilka, B. & Schertler, G. F. New G-protein-coupled receptor crystal structures: Insights and limitations. Trends Pharmacol. Sci. 29 79-83 (2008).
25. Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351-367 (2004).
26. Rohl, C. A., Strauss, C. E., Chivian, D. & Baker, D. Modeling structurally variable regions in homologous proteins with rosetta. Proteins 55, 656-677 (2004).
27. Friesner, R. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739-1749 (2004).
28. Totrov, M. & Abagyan, R. Flexible protein-ligand docking by global energy optimization in internal coordinates. Proteins 29 (Suppl. 1), 215-220 (1997).
29. Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W. & Taylor, R. D. Improved protein-ligand docking using GOLD. Proteins 52 609-623 (2003).
30. Morris, G. et al. Automated docking using a lamarkian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19, 1639-1662 (1998).
31. Mirzadegan, T., Benko, G., Filipek, S. & Palczewski, K. Sequence analyses of G-protein-coupled receptors: Similarities to rhodopsin. Biochemistry 42, 2759-2767 (2003).
32. Baker, D. & Sali, A. Protein structure prediction and structural genomics. Science 294, 93-96 (2001).
33. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G. & Schioth, H. B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272 (2003).
34. Marti-Renom, M. A. et al. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29 291-325 (2000).
35. Read, R. J. & Chavali, G. Assessment of CASP7 predictions in the high accuracy template-based modeling category. Proteins 69 (Suppl. 8), 27-37 (2007).
36. Kim, J. et al. Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition. Mol. Pharmacol. 49, 683-691 (1996).
37. Barth, P., Schonbrun, J. & Baker, D. Toward high-resolution prediction and design of transmembrane helical protein structures. Proc. Natl Acad. Sci. USA 104, 15682-15687 (2007).